BI
FHTX icon

BVF Inc’s Foghorn Therapeutics FHTX Stock Holding History

BVF Inc’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.5M Hold
5,842,000
– – 0.73% 29
2026
Q1 		$27.9M Buy
5,842,000
+540,000
+10% +$2.96M 0.89% 27
2025
Q4 		$28.6M Hold
5,302,000
– – 0.96% 28
2025
Q3 		$25.9M Hold
5,302,000
– – 1.05% 27
2025
Q2 		$24.9M Hold
5,302,000
– – 0.89% 21
2025
Q1 		$19.4M Hold
5,302,000
– – 0.79% 26
2024
Q4 		$25M Hold
5,302,000
– – 0.85% 25
2024
Q3 		$49.4M Hold
5,302,000
– – 1.44% 23
2024
Q2 		$30.5M Buy
+5,302,000
New +$31.6M 0.85% 29

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BVF Inc's FHTX Position: Q2 2026 in Review

BVF Inc held its Foghorn Therapeutics (FHTX) position steady in Q2 2026 at 5,842,000 shares worth $28.5M. The position accounts for 0.73% of the portfolio, ranked #29.

BVF Inc first reported a position in FHTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $49.4M in Q3 2024. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • BVF Inc held 5,842,000 shares of Foghorn Therapeutics worth $28.5M as of Q2 2026.
  • BVF Inc left its Foghorn Therapeutics share count unchanged in Q2 2026.
  • Foghorn Therapeutics made up 0.73% of BVF Inc's portfolio in Q2 2026, its #29 holding.
  • BVF Inc first reported a position in Foghorn Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • BVF Inc's Foghorn Therapeutics position peaked at $49.4M in Q3 2024.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.